• Text size      
  • Send this article to a friend
  • Print this article

Calls for MS drug to be used by NHS in Scotland

CAMPAIGNERS have urged Scotland's medicines regulator to reverse a decision to reject a new drug for patients with MS after the equivalent body south of the Border approved the same pill.

The Scottish Medicines Consortium (SMC) said the makers of fingolimod, the first tablet treatment for MS, did not show it was good value for money and the body chose not to recommend it for use on the NHS.

But now the National Institute for Health and Clinical Excellence (Nice), which rules on drugs in England and Wales, has revealed draft guidance recommending fingolimod, whose brand name is Gilenya, for prescription on the NHS for some patients with relapsing-remitting multiple sclerosis.

It raises the prospect of a north-south divide for patients, even although Scotland suffers the highest rate of MS in the world, with 10,500 people diagnosed with the condition.

Dr Belinda Weller, a neurologist at the Western General in Edinburgh who led the Scottish clinical trial of fingolimod, said: "It's going to be quite hard for our patients in Scotland who are aware that people over the Border are going to be having access to this.

"But I'm also hopeful that with that decision there will be more pressure on the regulatory body in Scotland to reconsider the decision."

Fingolimod can help reduce the number of relapses in adults with relapsing-remitting multiple sclerosis.

A spokesman for the SMC said: "Sometimes SMC has to make very difficult decisions and we are acutely aware that our decisions have an impact on patients."

Commenting & Moderation

We moderate all comments on HeraldScotland on either a pre-moderated or post-moderated basis.
If you're a relatively new user then your comments will be reviewed before publication and if we know you well and trust you then your comments will be subject to moderation only if other users or the moderators believe you've broken the rules

Moderation is undertaken full-time 9am-6pm on weekdays, and on a part-time basis outwith those hours. Please be patient if your posts are not approved instantly.